No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
No Data
Alterity Therapeutics Initiated at Buy by Maxim Group
Alterity Therapeutics' Vision for Neurodegenerative Care | NYSE:ATHE, ASX:ATH
Press Release: Alterity Therapeutics Appoints Abby Macnish Niven as Chief Financial Officer
Alterity Therapeutics Names New CFO; Shares Down 25%
Alterity Therapeutics Ltd: Annual Report 2024
Alterity Therapeutics Ltd: Appendix 4E Preliminary Final Report